Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept for Myocarditis in Rheumatoid Arthritis
NCT03619876Phase 4Terminated
- Sponsor
- Columbia University
- Start
- Jul 2019
- Primary completion
- Sep 2021
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of abatacept in rheumatoid arthritis (RA), myocarditis, sponsored by Columbia University. Started Jul 2019; status: terminated.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)myocarditis
Beyond the preview
Go deeper on NCT03619876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03619876.